Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters

Publication year range
6.
Environ Microbiol ; 16(4): 963-76, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24034719

ABSTRACT

Shiga toxin (Stx)-producing Escherichia coli (STEC) of serogroup O174 are human pathogenic intimin gene (eae)-negative STEC. To facilitate diagnosis and subtyping, we genotypically and phenotypically characterized 25 STEC O174 isolates from humans with different clinical outcomes and from animals and the environment. fliC genotyping resulted in four different genotypes (fliCH2 : n = 5; fliCH8 : n = 8; fliCH21 : n = 11; fliCH46 : n = 1). Twenty-three strains were motile expressing the corresponding H antigen; two non-motile isolates possessed fliCH8 . The stx genotypes and non-stx virulence loci, including toxins, serine-proteases and adhesins correlated well with serotypes but showed no differences with respect to the isolates' origins. Multilocus sequence typing identified seven sequence types that correlated with serotypes. Core gene typing further specified the four serotypes, including a previously unknown O174:H46 combination, and revealed distant relationships of the different serotypes within serogroup O174 and in relation to other haemolytic uremic syndrome (HUS)-associated STEC. Only serotype O174:H21 was associated with HUS. Differences in virulence factors and in the adherence capacity of STEC O174 corroborated this separation into four distinct groups. Our study provides a basis for O174 subtyping, unravels considerable genotypic and phenotypic heterogeneity and sheds light to potential environmental and animal reservoirs.


Subject(s)
Escherichia coli Proteins/genetics , Shiga Toxin/genetics , Shiga-Toxigenic Escherichia coli/physiology , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion , Cattle , Cell Line , Chlorocebus aethiops , Drug Resistance, Multiple, Bacterial , Escherichia coli Proteins/toxicity , Genotype , Humans , Intestinal Mucosa/microbiology , Molecular Sequence Data , Multilocus Sequence Typing , Phenotype , Phylogeny , Shiga Toxin/toxicity , Shiga-Toxigenic Escherichia coli/drug effects , Shiga-Toxigenic Escherichia coli/isolation & purification , Vero Cells
9.
Article in German | MEDLINE | ID: mdl-19194679

ABSTRACT

The basis for EU wide surveillance was Decision 2119/98/EC of the European Parliament and the Council in 1998. Since May 2005 it is the task of the European Centre for Disease Prevention and Control to coordinate and further develop this network. One key function of the ECDC is to standardise European surveillance and especially to harmonise the procedures of the surveillance networks that developed independently of each other. As a first step, the EU case definitions have been revised jointly with the Member States and the Commission. All surveillance networks are evaluated with a standard protocol before a decision is made at the ECDC on the continuation of the individual network activities. Simultaneously, the development of The European Surveillance System (TESSy) progressed. Since the beginning of 2008 data users have been trained and TESSy has been in use since April 2008. In the future the main focus must be the improvement of the quality and comparability of the data as such data are the essential prerequisite for decision making in public health.


Subject(s)
Communicable Disease Control/standards , European Union/organization & administration , Global Health , International Cooperation , Population Surveillance/methods , Communicable Disease Control/organization & administration , Europe , Forecasting , Humans , Medical Informatics Computing/standards , Medical Informatics Computing/trends , Public Health Practice/standards , Quality Assurance, Health Care/standards , Reference Standards , Sentinel Surveillance
10.
Clin Infect Dis ; 44(11): e88-95, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17479931

ABSTRACT

BACKGROUND: Skin infections due to Staphylococcus aureus have recently become a public concern, mainly because of emerging resistance against widely used antibiotics and specific virulence determinants. Strains harboring the lukS-lukF gene (which codes for Panton-Valentine leukocidin) are frequently associated with severe furunculosis. Generally applicable strategies for the control of community outbreaks of furunculosis have not been defined. METHODS: We report the investigation and successful termination of an outbreak of furunculosis due to lukS-lukF-positive S. aureus in a German village (n=144). Nasal swab specimens were obtained from village residents. A retrospective cohort study was conducted. Nasally colonized persons, persons who had current furuncles or who had experienced relapsing furuncles since 2002, and their family members underwent stringent decolonization measures using mupirocin nasal ointment and disinfecting wash solution. Multiple nasal swab specimens were obtained to monitor the long-term outcome of decolonization measures. RESULTS: From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding. Of 140 participants tested, 51 (36%) were found to be nasally colonized with S. aureus. In 9 participants, the strain was positive for lukS-lukF. No methicillin resistance was detected. Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9). Passive surveillance implemented in January 2005 did not detect any case of lukS-lukF-positive, S. aureus-associated furuncles in this village. CONCLUSION: This report describes a successful strategy for terminating the transmission of epidemic strains of S. aureus among a nonhospitalized population.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Disease Outbreaks/prevention & control , Furunculosis/drug therapy , Furunculosis/epidemiology , Mupirocin/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Proteins/genetics , Child , Child, Preschool , Cohort Studies , Drug Resistance, Bacterial , Female , Furunculosis/microbiology , Germany , Humans , Infant , Infant, Newborn , Leukocidins/genetics , Male , Methicillin Resistance , Microbial Sensitivity Tests , Middle Aged , Mupirocin/administration & dosage , Retrospective Studies , Risk Factors , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Treatment Outcome
11.
Emerg Infect Dis ; 13(10): 1548-55, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18258005

ABSTRACT

In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet) for infectious disease outbreaks in Germany. SurvNet has captured 30,578 outbreak reports in 2001-2005. The size of the outbreaks ranged from 2 to 527 cases. For outbreaks reported in 2002-2005, the median duration from notification of the first case to the local health department until receipt of the outbreak report at RKI was 7 days. Median outbreak duration ranged from 1 day (caused by Campylobacter) up to 73 days (caused by Mycobacterium tuberculosis). The most common settings among the 10,008 entries for 9,946 outbreaks in 2004 and 2005 were households (5,262; 53%), nursing homes (1,218; 12%), and hospitals (1,248; 12%). SurvNet may be a useful tool for other outbreak surveillance systems because it minimizes the workload of local health departments and captures outbreaks even when causative pathogens have not yet been identified.


Subject(s)
Database Management Systems , Disease Notification/methods , Disease Outbreaks , Internet , Population Surveillance/methods , Germany/epidemiology , Humans , Public Health Informatics , Sentinel Surveillance
12.
BMC Infect Dis ; 5: 7, 2005 Feb 03.
Article in English | MEDLINE | ID: mdl-15691371

ABSTRACT

BACKGROUND: This report describes a large international chocolate-associated Salmonella outbreak originating from Germany. METHODS: We conducted epidemiologic investigations including a case-control study, and food safety investigations. Salmonella (S.) Oranienburg isolates were subtyped by the use of pulsed-field gel electrophoresis (PFGE). RESULTS: From 1 October 2001 through 24 March 2002, an estimated excess of 439 S. Oranienburg notifications was registered in Germany. Simultaneously, an increase in S. Oranienburg infections was noted in other European countries in the Enter-net surveillance network. In a multistate matched case-control study in Germany, daily consumption of chocolate (matched odds ratio [MOR]: 4.8; 95% confidence interval [CI]: 1.3-26.5), having shopped at a large chain of discount grocery stores (MOR: 4.2; CI: 1.2-23.0), and consumption of chocolate purchased there (MOR: 5.0; CI: 1.1-47.0) were associated with illness. Subsequently, two brands from the same company, one exclusively produced for that chain, tested positive for S. Oranienburg. In two other European countries and in Canada chocolate from company A was ascertained that also contained S. Oranienburg. Isolates from humans and from chocolates had indistinguishable PFGE profiles. No source or point of contamination was identified. Epidemiological identification of chocolate as a vehicle of infections required two months, and was facilitated by proxy measures. CONCLUSIONS: Despite the use of improved production technologies, the chocolate industry continues to carry a small risk of manufacturing Salmonella-containing products. Particularly in diffuse outbreak-settings, clear associations with surrogates of exposure should suffice to trigger public health action. Networks such as Enter-net have become invaluable for facilitating rapid and appropriate management of international outbreaks.


Subject(s)
Cacao/microbiology , Candy/microbiology , Disease Outbreaks , Food Microbiology , Salmonella Food Poisoning/microbiology , Salmonella/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Canada/epidemiology , Case-Control Studies , Child , Child, Preschool , Electrophoresis, Gel, Pulsed-Field/methods , Europe/epidemiology , Female , Germany/epidemiology , Humans , Infant , Male , Middle Aged , Risk Factors , Salmonella/genetics , Salmonella Food Poisoning/epidemiology
13.
Euro Surveill ; 2(12): 91-96, 1997 Dec.
Article in English | MEDLINE | ID: mdl-12631786

ABSTRACT

Since they were first described, Escherichia coliO157: H7 and other related enterohaemorrhagic E. coli(EHEC) have become known as a major infectious cause of bloody diarrhoea. These E. coliproduce one or more shiga-toxins (stx) or Vero cytotoxins. Strictl

14.
Euro Surveill ; 5(11): 120-123, 2000 Nov.
Article in English | MEDLINE | ID: mdl-12631962

ABSTRACT

A network of epidemiologists, microbiologists, veterinarians, and clinicians is being developed in Germany to support local and state health departments and veterinary authorities in their research and epidemiological investigations on emerging foodborne

15.
Euro Surveill ; 8(11): 207-13, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14684880

ABSTRACT

Two surveys have been conducted on behalf of the Campylobacter Working Group with the aim of assessing the feasibility of a European network on human Campylobacter infections. The first survey, conducted in 18 countries, collected information about diagnostic methods used for surveillance purpose while the second one, conducted among 10 European countries, gathered data on diagnostic methods and procedures in primary laboratories. Seventeen of the 18 countries had a surveillance system for Campylobacter infections and 13 a national reference laboratory. The case definition used for the surveillance in all these countries included laboratory confirmation. No commonly applicable subtyping methods were applied. Concerning primary laboratories dealing with Campylobacter infections, only a few of them reported directly to the national level, and antimicrobial susceptibility testing was performed by about half of the laboratories. These surveys indicated that a basic infrastructure for a wide European Campylobacter surveillance exists.


Subject(s)
Campylobacter Infections/diagnosis , Campylobacter Infections/epidemiology , Campylobacter/isolation & purification , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/therapeutic use , Campylobacter/classification , Campylobacter/drug effects , Campylobacter Infections/classification , Campylobacter Infections/drug therapy , Data Collection/methods , Drug Resistance, Bacterial , Europe/epidemiology , Feasibility Studies , Health Planning Guidelines , Humans , Laboratories/standards , Microbial Sensitivity Tests/classification , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/trends , Population Surveillance/methods , Quality Assurance, Health Care/methods , Quality Assurance, Health Care/standards , Sentinel Surveillance , Surveys and Questionnaires
16.
Euro Surveill ; 4(7): 78-81, 1999 Jul.
Article in English | MEDLINE | ID: mdl-12631894

ABSTRACT

Illness or death from trichinellosis is statutorily notifiable in Germany. Between nought and ten cases were reported each year from 1987 to 1997. From November 1998 to January 1999, however, 52 cases of trichinellosis were identified by the public health

20.
Int J Food Microbiol ; 139 Suppl 1: S43-7, 2010 May 30.
Article in English | MEDLINE | ID: mdl-20395001

ABSTRACT

The European Community (EC) has been collecting for 15 years data on zoonoses and agents thereof that integrate the information from human cases and their occurrence in food and animals. The current data collection covers 11 zoonotic agents: Salmonella, Campylobacter, Listeria, verotoxigenic E. coli (VTEC), Yersinia spp., Brucella, Mycobacterium bovis, Trichinella and Echinoccoccus, as well as rabies and food-borne outbreaks. The European Food Safety Authority (EFSA) is assigned the tasks of examining the data collected and publishing the Community Summary Report. This Report is prepared in close collaboration with the European Centre for Disease Prevention and Control (ECDC) responsible for the surveillance of the communicable diseases in humans, and with EFSA's Zoonoses Collaboration Centre (ZCC, in the Technical University of Denmark). Member States report the data on animals, feed, food and food-borne outbreaks to EFSA's web-based reporting system and the data on the human cases are reported to ECDC's web-application for The European Surveillance System (TESSy). The flow and analysis of data are described as well as an outline of the future plans to improve the comparability of the data.


Subject(s)
Data Collection , European Union , Foodborne Diseases/epidemiology , Statistics as Topic , Zoonoses/epidemiology , Animals , Food Microbiology , Food Parasitology , Foodborne Diseases/microbiology , Foodborne Diseases/parasitology , Foodborne Diseases/virology , Humans , Zoonoses/microbiology , Zoonoses/parasitology , Zoonoses/virology
SELECTION OF CITATIONS
SEARCH DETAIL